King's College London

Research portal

The urology cancer MDT; What can be improved? Association of Surgeons in Training 2018 Conference

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)S131
JournalInternational Journal Of Surgery
Volume55
Early online date2 Aug 2018
DOIs
E-pub ahead of print2 Aug 2018
Published2018

King's Authors

Abstract

Aim: To compare current urology MDT practice to other major cancers and identify areas urology MDT members wish to improve and prioritise.

Method: Cancer Research UK sent a survey to UK MDT members in 2017 comprising questions about the importance and implementation of 13 critical areas. Answers were provided on a six-point scale (1 = not important / never done; 6 = extremely important / always done). We analysed data from urology MDT members compared to responses from the other most prevalent cancers: breast, lung and colorectal.

Results: 1759/2304 respondents were included for analyses, including 197 from urology MDTs. Urology MDTs rated the following as important but poorly implemented: prioritisation of complex patients, auditing of MDT decisions and sufficient preparation time within job plans (mean Likert scores for importance: 4.0, 4.7 and 5.4, and implementation: 2.8, 3.2 and 3.1, respectively). Different professional groups within the urology MDTs showed agreement on all questions. There was excellent concordance between urology and the other tumour types for all factors.

Conclusions: Current practices within urology MDTs are similar to those of the other major cancers. Key areas for modernisation include how best to prioritise complex cases, improve auditing of decisions, and ensuring adequate preparation time for MDT members.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454